chrisvoncsefalvay/vaers-outcomes huggingface dataset:
unable to put pressure on left arm where vaccination was administered. Pain rotates from elbow to back shoulder plate.
pt recv vax 14OCT93 & 2 wk later exp shoulder, neck & back pain, subsequently the pain extended to the hips & knees; No further details were provided;
Localized swelling left arm above are of injection. 48 hours of symptoms. Treated by primary care physician. Benadryl Cortisone resolved in 24 hours.
Pt has pain in left arm which is radiating to her axilla area and into her breast area. She reports no appetite and feeling rather lethargic. She also states she has bruising on left arm. She had fallen earlier in the week and had a bruise on her elbow.
Headache, Myalgia, NauseaVomiting,  weakness, sore arm Narrative:
Patient complained of bodyache, fever, cough, muscle/joints pain, and flu like symptoms.
Redness all around injection site around arm, hard swollen. Right arm only. Child complained of soreness. Mother of child called to report reaction on 5/21/03. On 5/22/03 follow up call. Symptoms were resolving.
Bivalent COVID vaccine was given after being declared no longer authorized. We didn't receive email notification of it no longer being authorized until later in the evening on 9/12/23 and patient had an early AM appt on 9/13/23. No issues for the baby after vaccine was given.
I am post menopausal and my last period before this was February of 2017. Exactly 7 days after the second shot I started experiencing PMS symptoms (breast tenderness), then 7 days after that my period started. This is the first period I've had in four years and it is heavy, with cramps lasting longer than what used to be normal for me.
Right arm pain at injection site; fever; could not raise arm for several days; loss of appetite for several days; headaches for 1-2 days; increased swelling, rash, and redness from shoulder to elbow of right arm.
I had the Johnson & Johnson vaccine and had a bad headache two days after and still have a slight headache five days after. I also have pretty bad fatiuge. All symptoms started 4/5 hours after getting the vaccine including nausea, headache, chills, fever (of almost 103), chest pains, fatigue, body/arm pain, ear pain. The ear pain started 3 days after the shot.   I tried calling one of the doctors in our network around and they both denied me even though the symptoms were from the vaccine...
Patient reports nausea, white foam eruptions from mouth, chills, and increased heart rate.
Pt recvd vax 28JUL92 & 24 hrs following vax pt devel URI w/h/a, dry cough & myalgia; also devel pharyngitis, extreme fatigue, weakness, & malaise;
7 days after the second dose started with local arm pain and shooting pain episodes. First and second dose only local pain  for 2 days when administered
shingrix vaccine dose # 2 on Thursday  June 22, 2023 around 3:55 PM. Pt. came to pharmacy on Saturday June 24, 2023 and reported her adverse reaction on the injection site, which was red and warm, diameter of tennis ball. Redness started Saturday morning and patient marked the redness with a sharpie and monitored the size. It started to move past the marked area so patient sought medical attention and took antibiotic Ciprofloxacin for presumed cellulitis.
After 5 minutes of receiving covid Pfizer vaccine I started experimenting these symptoms: sweating, feeling of suffocation,  dizziness, my body started shaking specially my right leg.
Patient was seen on 07/06/2021 for ER follow up. Pt. went to the ER  due to having a GERD flare-up.  Pt. had sx of vomiting, inability to keep fluids down, severe headaches and fatigue. ER started pt. on Pantoprazole and advised pt. to f/u with PCP on Monday. Pt. stated that her headache was immediately after injection and still had a headache at time of OV. FNP  increased Pantoprazole 20MG to 40MG and gave pt. rx for Ondansetron. PCP also stopped pt. Nexium and started pt. on Carafate 1GM.
2/22 Initial onset of lesions in diaper area (blisters) FNP prescribed Amoxil for treatment of staph of lesion on buttock and several (2-3) inguinal fold 2/27, not thought to be related to shots.
FLUMIST given to 2 y.o. male with history of asthma. Patient had wheezing that started prior to visit 10/22/08. Mother treating at home with albuterol. On day of visit, patient was clear to auscultation on exam. Patient was accidentaly given FLUMIST instead of FLUZONE. There was no immediate wheezing following FLUMIST, and prior to patient leaving office.
Patient presented with a red, warm, itchy rash about 4 inches in diameter around the injection site.
she received quite a strong immune response after the second dose; she expected to feel lousy and she received quite a strong immune response after the second dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 76 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: IMMUNE-MEDIATED ADVERSE REACTION (non-serious), outcome "unknown", described as "she received quite a strong immune response after the second dose"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "she expected to feel lousy and she received quite a strong immune response after the second dose".  Additional information: Patient reported she just her Pfizer booster on Saturday and had no side effects  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Soreness at injection site for 3 days, itchy at the injection site for 1 day
TRAUMA; DESPERATION; DEPRESSION; CRAMPS ON HAND; NAUSEA; ANXIETY; INSOMNIA; WEIGHT LOSS (LOST 8LB IN THE FIRST 2 MONTHS); LOSS OF APPETITE; BLURRED VISION; DARK SPOTS ON VISUAL FIELD (RIGHT EYE); CRAMPS ON SOLE OF FEET; MUSCULAR PAIN IN BOTH LEG PAIN AND LOWER BACK; This spontaneous report received from a patient concerned a 39 year old female. The patient's weight was 148 pounds, and height was 157 centimeters. The patient's concurrent conditions included low cholesterol, prediabetes, non alcoholic, non smoker, seasonal allergies, and shrimps and sea food allergy, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient was previously treated with Pfizer vaccine (BNT 162) as per workplace policies for prophylactic vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, one total, vaccinated at right arm on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-APR-2021, the patient experienced muscular pain in both leg pain and lower back. Pain worsen after consumer soaked feet and lower legs in warm water and Epson salts for 20 min. Patient went 5 times in 3 months to ER due to pain. Patient went to doctor who referred to a physical therapist who ordered an MRI, patient had not done it because of anxiety. Pain caused patient to stop working. Patient described situation as trauma and desperation, depression. On 14-APR-2021, the patient experienced cramps on sole of feet that wouldn't let her walk at times. On 21-APR-2021, the patient experienced blurred vision and dark spots on visual field (right eye) that started about a week and half after inoculation. Patient will be seeing an eye specialist this month. On 25-APR-2021, the patient experienced anxiety, insomnia. weight loss (lost 8lb in the first 2 months), loss of appetite, nausea. Laboratory data included: Weight loss (NR: not provided) lost 8lb in the first 2 monthsPatient Took drops to sleep once to help insomnia. On 30-APR-2021, Laboratory data included: Blood test (NR: not provided) Samples okay, and Urine analysis (NR: not provided) Samples okay. On 22-JUN-2021, the patient experienced cramps on hand. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from insomnia, loss of appetite, and cramps on sole of feet, had not recovered from muscular pain in both leg pain and lower back, anxiety, blurred vision, dark spots on visual field (right eye), and cramps on hand, and the outcome of weight loss (lost 8lb in the first 2 months), nausea, trauma, desperation and depression was not reported. This report was serious (Other Medically Important Condition). .; Sender's Comments: V0:20210727678-covid-19 vaccine ad26.cov2.s-Muscular pain in both le and lower back. This event(s) is labeled per Agency and is therefore considered potentially related.
Started 12 hrs. after vaccine, slight fever of 99-100 and chills, sore arm at injection site, lasted only 12 hours. Then on day 7 erupted with HERPATIC LESIONS / BLISTERS all over buttocks and still having off and on outbreaks constantly of HSV2, I have never had herpes outbreaks in 54 years of my LIFE!!!!! I have been in constant herpes outbreaks since 11/10/21 after the 3rd vaccine and it is now mid Feb. 2022!
a dose of Infanrix was given to an 8 year old patient. The patient was supposed to be given Boostrix.; a dose of Infanrix was given to an 8 year old patient. The patient was supposed to be given Boostrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old female patient who received DTPa (Infanrix) (batch number 9R2D7, expiry date 23-MAY-2025) for prophylaxis.   On an unknown date, the patient received Infanrix. On an unknown date, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: a dose of Infanrix was given to an 8 year old patient. The patient was supposed to be given Boostrix.) and wrong vaccine administered (Verbatim: a dose of Infanrix was given to an 8 year old patient. The patient was supposed to be given Boostrix). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 11-SEP-2023 The nurse practitioner reported a 8 year old patient who was supposed to administered the Boostrix was administered with Infanrix which lead to wrong vaccine administration and Inappropriate age at vaccine administration. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.
Severe, deep aching pain began to occur through my entire right and left arms. Deep spasms, deep unbearable joint pain in both elbows, deep spasms throughout every muscle in both arms. Can hardly sleep. Numbness in both hands, freezing cold hands. Terrible muscle weakness. Very painful to lift a glass of water and at times need to use two hands to drink the glass of water. Can barely pick up a pot or anything with any weight. Even to pull a blanket up once in bed is terribly painful. To do anything with arms, deep pain. It has been two months, and symptoms have progressed into freezing cold hands and a continuation of above symptoms.
arm was very sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was very sore) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was very sore). At the time of the report, PAIN IN EXTREMITY (arm was very sore) outcome was unknown. Not Provided          No concomitant medications was reported Treatment information provided as "Ice" to treat the events
2 weeks after developed shingles /she developed shingles two weeks after receiving the first dose of the vaccine; This is a spontaneous report from a Pfizer. A contactable consumer reported that a 67-year-old female patient (consumer) received first dose BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, Solution for injection) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Patient medical history and concomitant medications were not reported. Swap 3 weeks ago but 2 weeks after developed shingles and was asking if she got shingles from the COVAX or because she never got the vaccine for shingles. She was due for second COVAX on Sunday. Her HCP told her she should get the COVAX she was confirming. It was mentioned she developed shingles two weeks after receiving the first dose of the vaccine on an unspecified date. She wants to know if this side effect was associated with the vaccine. She mentioned it could be related to stress or the fact she have not received the shingles vaccine yet. It was asked as would her condition (shingles) have an impact on the efficacy of the vaccine. She want to be 95 % protected not less than that. Her HCP has recommended the second dose but she just want to verify this information with them. Outcome of event was unknown.  Information on lot/batch number has been requested.
Began on 10/8/00 with "pimples" on various body parts. Per mother temperature was 100F-102.4F (oral), dry cough (day and night). On 10/13/00, dx'd in office with URI and varicella zoster.
Right sided weakness, double vision, slurred speech Narrative: This patient chose not to seek care for further eval due to DNR status. Nursing documentation from 4/9 visit entered above.
pt had varivax 20SEP96 & has a heavy case of chickenpox @ present time since 18MAY98 c/o stomach ache-mouth ulcers-mom states feels hot no therm exposed to sibling;
Rash,itching, swallen lymphnoids,fatigue, nausea,headache,blood pressure rise,blood sugar rise,
Pt developed rash, red itchy bumps, to lower extremities and buttock a few hours after flu shot . MOP administer benardryl at home and was seen by provider then next day.   Labs were sent for food allergy profile and follow up appointment made for 5 days.
Extreme pain limiting range of motion which is not relieved by OTC pain medication. After six months it is getting worse - keeping me awake at night and radiating to my shoulder, neck with numbness all the way to my fingers.
Patient underage of 18 years old. Patient is currently on 17 years of age.
Case number PHEH2016US029744, is an initial spontaneous report received from a pharmacist on 09 Nov 2016. This report refers to a female patient of unknown age. Past medical history and concomitant medications were not reported. The patient was vaccinated with a single dose of FLUVIRIN (batch number: 158302, Expiry date: Jun 2016) at a dose of 0.5 ml, intramuscularly on 13 Oct 2016. On same day the patient was vaccinated with last years formulation of FLUVIRIN vaccine. The pharmacist stated that, last years FLUVIRIN vaccine was given to two staff members. The pharmacist inquired that if they should received this years dose of the vaccine or not and when they should be revaccinated. No adverse event was reported following this medication error (expired product administered).
adverse reaction; This case was reported by a physician via call center representative and described the occurrence of adverse reaction in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The health care professional reported that many patients had Adverse reaction associated with Shingrix. The doctor would not provide any additional information.  The reporter did not consent to follow-up. This case linked with US2019209063, reported by same reporter.
suspected vaccination failure; Shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included chemotherapy.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported the case for herself/himself. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication.  The patient got the shingles after the shot. The reporter mentioned that, seeing so many said shingles shortly after was a clue. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible, as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR093045:same reporter (Invalid case)
1 hour after vaccination, became nauseated with severe headache. This progressed to chills, sweating, and extreme tiredness, with all over body aches. Presented to the ED with chief complaint of severe myalgia and arthralgia head to toe.
headache; chills; his left arm and shoulder ache; Shoulder ache; This is a spontaneous report from a contactable consumer (patient). A 63-years-old male patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: ER8732), dose 2 via an unspecified route of administration, administered in Arm Left on 17May2021 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 63 years). Medical history included hypertension and diabetes mellitus from an unknown date and unknown if ongoing. ketoconazole and experienced drug hypersensitivity. The patient's concomitant medications were not reported. The patient previously took bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EP6955), dose 1 via an unspecified route of administration, administered in Arm Left on 26Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, the patient has not been tested for COVID-19. The patient experienced on 18May2021 that this is the next day after receiving vaccine, headache, chills and his left arm and shoulder ache. Just doesn't feel good. Tylenol given. Therapeutic measures were taken as a result of all the adverse events included with the product Tylenol. The clinical outcome of the events headache, chills, his left arm and shoulder ache, shoulder ache were recovering.   Follow-up (23Jun2021): Follow-up attempts completed. No further information expected.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 at 12:00 as dose 5 (booster), single (Lot number: GH9694) at the age of 79 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3, single (Batch/Lot number: unknown) and as dose 4, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Gillian Barre Syndrome", start date: 2000 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Known allergies were reported as No.
No additional AE,; the vaccine expired 12-SEP-2020 and was administered 18-DEC-2020; This spontaneous report as received from a pharmacy technician refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 18-DEC-2020, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 0.5 ml, expiration date: 09-DEC-2020 (lot # and route of administration were not reported) for prophylaxis. No additional adverse event was reported.
After receiving the vaccine patient reported feeling faint, hot, and having a hard time breathing. Requested that rescue be called.  Rescue took her blood pressure and it was low, patient denied transportation
Respiratory issues; This case was reported by a physician via sales rep and described the occurrence of respiratory disorder in a female patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced respiratory disorder. On an unknown date, the outcome of the respiratory disorder was unknown.   It was unknown if the reporter considered the respiratory disorder to be related to Pediarix and Pediarix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. Health care professional reported that the patient experienced respiratory issue after receiving Pediarix. The dates of the event, the lot number or expiration dates were unknown. No further details were known. The health care professional gave permission to be contacted concerning event. The reporter consented to follow up. This case is one of the 10 cases reported by same reporter.
Administration error: mixed manufacture regimen. The individual was vaccinated with the Pfizer product on 01/22/2021 and the Moderna product on 02/23/2021.  Also breakthrough COVID-19 disease after which death occurred. The individual had an ongoing issue with a non-healing foot ulcer for which they were hospitalized 08/11/2021-08/24/2021. They were subsequently transferred to a different facility (Hospital), on 08/25/2021 for a surgery related to this ongoing issue. where they tested positive on 08/25/2021 after becoming symptomatic with fever, chills, and "respiratory symptoms." While hospitalized, the individual developed stroke-like symptoms but CT head scan was negative for acute stroke processes. They were transferred to Medical Center on 09/02/2021, where stroke was confirmed. They remained hospitalized until their death on 09/07/2021, after being placed on comfort care given poor prognosis.